Sartorius Aktiengesellschaft (XTRA:SRT) entered into an agreement to acquire 62.5% stake in ALS Automated Lab Solutions GmbH for approximately €24 million on December 16, 2021. Sartorius Aktiengesellschaft is initially purchasing 62.5% of the shares in ALS Automated Lab Solutions GmbH. The remaining 37.5% will be acquired in 2026. ALS Automated Lab Solutions GmbH currently employs around 30 people and is expected to generate sales in the high single-digit million-euro area in 2021, with a double-digit EBITDA margin. Michael Bernhardt, Matthias Schell, Alexander Rinne and Leopold Riedl of Milbank LLP acted as legal advisors to Sartorius Aktiengesellschaft. Landpoint Corporate Finance GmbH acted as financial advisor to owners of Als Automated Lab Solutions Gmbh in the transaction.

Sartorius Aktiengesellschaft (XTRA:SRT) completed the acquisition of a 62.5% stake in ALS Automated Lab Solutions GmbH on January 4, 2022.